COMMUNIQUÉS West-GlobeNewswire

OncoBag launches innovative handbag for post-mastectomy women
02/06/2026
Polish Femtech pioneer begins pre-sales of revolutionary OncoBag Wroclaw, Poland, June 02, 2026 (GLOBE NEWSWIRE) -- OncoBag, a pioneering Polish femtech and wellness company, has announced the pre-sale of its [...]
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
02/06/2026
Research from Tiny Health and Free to Feed, published in Frontiers in Microbiomes, finds the gut microbiomes of infants with eczema or food allergies begin to look different from healthy peers as early as 6 months old [...]
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa as chief technology [...]
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
02/06/2026
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security NETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American [...]
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
02/06/2026
MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA (TSX-V: PHA) ( “Premier Health” , or the “Company” ) announces that the Company’s unaudited interim financial statements and the related management’s [...]
Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
02/06/2026
New product range introduces targeted probiotic oral care solutions for everyday wellness routines Oraticx Logo LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- Oraticx, a wellness brand focused on oral microbiome balance [...]
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling. The [...]
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
02/06/2026
Promising Phase 1 data for LB2501, a potential first ‑ in ‑ class CD19/CD20 dual ‑ targeting in vivo CAR-T therapy, as an off-the-shelf, single-infusion treatment for B ‑ cell malignancies An ORR of 100% (6/6) was [...]
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically active [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026
CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
02/06/2026
- The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program - - 30 mg onvansertib + FOLFIRI/bevacizumab arm showed a [...]
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
02/06/2026
June 2, 2026 Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound AI-powered workflow automation helps clinicians acquire high- [...]
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
02/06/2026
IRVING, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is proud to announce its continued support of the OMS Foundation with a gift-match incentive for the Foundation’s mid-year [...]
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
02/06/2026
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Jersey College , the institution dedicated to excellence in nursing education, [...]
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four [...]
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
02/06/2026
U.S. Naloxone Market: ~$141 million in annual sales and 9.4 million units annually COMMACK, NY, June 02, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned [...]

Pages